TrialLancet (London, England)2016

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.

Richard G Margolese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.